Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening

Kwang-Ho Lee1, Tae-Hyung Kim1

  • 1School of Integrative Engineering, Chung-Ang University, 84 Heukseuk-ro, Dongjak-gu, Seoul 06974, Korea.

Biosensors
|November 25, 2021
PubMed

Insights

Multicellular tumor spheroids (MCTs) offer a 3D model for studying cancer and drug effects. Advanced culture and biosensing techniques enhance drug screening accuracy for better cancer therapeutics.

Area of Science:

  • Biomedical Engineering
  • Cancer Research
  • Drug Discovery

Background:

  • Multicellular tumor spheroids (MCTs) are valuable 3D models for solid tumors.
  • Mimicking the tumor extracellular matrix (ECM) is crucial for understanding cellular interactions.
  • MCTs offer improved mimicry of in vivo tumors for drug cytotoxicity assessments.

Purpose of the Study:

  • To review trends in 3D spheroid culture technologies and platforms.
  • To explore the integration of biosensing techniques with spheroid models for drug screening.
  • To highlight advancements in creating realistic tumor microenvironments for research.

Main Methods:

  • Development of advanced 3D multicellular spheroid culture technologies.
  • Integration of materials science and biosensing techniques for tumor modeling.
  • Application of invasive and non-invasive drug screening methods using spheroids.

Main Results:

  • Various 3D spheroid culture technologies have been established for research.
  • Biosensing techniques combined with spheroid platforms enable precise drug screening.
  • MCTs accurately represent anticancer drug efficacy in a tumor-like environment.

Conclusions:

  • 3D spheroid culture and biosensing technologies are advancing cancer research and drug development.
  • These integrated approaches provide a more accurate platform for evaluating drug candidates.
  • The review highlights the potential of these technologies for future biomedical applications.

Related Concept Videos